Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: A comparison of tricyclo-DNA with LNA

Nucleic Acids Research

Volumn 32, Issue 1, 2004, Pages 346-353

  Ittig, Damian ^a   Liu, Songkai ^a   Renneberg, Dorte ^a   Schümperli, Daniel ^a   Leumann, Christian J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CARRIER PROTEIN; CYCLOPHILIN A; FLUORESCEIN; LIPID; LIPOFECTAMINE; MESSENGER RNA PRECURSOR; OLIGOMER; OLIGONUCLEOTIDE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CHEMICAL LABELING; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FLUORESCENCE ANALYSIS; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; RNA SYNTHESIS; VIRUS REPLICATION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL NUCLEUS; CYCLOPHILIN A; DOWN-REGULATION; EXONS; HELA CELLS; HIV-1; HUMANS; LIPIDS; MICROSCOPY, FLUORESCENCE; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; RNA PRECURSORS; RNA SPLICE SITES; RNA SPLICING; RNA STABILITY; THERMODYNAMICS; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1242297789     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh187     Document Type: Article

References (41)

1. Vacek,M., Sazani,P. and Kole,R. (2003) Antisense-mediated redirection of mRNA splicing. Cell, Mol. Life Sci, 60, 825-833.
2. Kurreck,J. (2003) Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem., 270, 1628-1644.
3. Friedman,K.J., Kole,J., Cohn,J.A., Knowles,M.R., Silverman,L.M. and Kole,R. (1999) Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFFR) gene by antisense oligonucleotides. J. Biol. Chem., 274, 36193-36199.
4. Karras,J.G., McKay,R.A., Dean,N.M. and Monia,B.P. (2000) Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing. Mol. Pharmacol., 58, 380-387.
5. Giles,R.V., Spiller,D.G., Clark,R.E. and Tidd,D.M. (1999) Antisense morpholino oligonucleotide analog induces missplicing of C-mye mRNA. Antisense Nucleic Acid Drug Dev., 9, 213-220.
6. Kalbfus,B., Mabon,S.A. and Misteli,T. (2001) Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. J. Biol. Chem., 276, 42986-42993.
7. Lim,S.R. and Hertel,K.J. (2001) Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing. J. Biol. Chem., 276, 4547-45483.
8. Mercatante,D.R., Mohler,J.L. and Kole,R. (2002) Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. J. Biol. Chem., 277, 49374-49382.
9. Taylor,J.K., Zhang,Q.Q., Wyatt,J.R. and Dean,N.M. (1999) Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol, 17, 1097-1100.
10. Mercatante,D.R., Bortner,C.D., Cidlowki,J.A. and Kole,R. (2001) Modification of alternative splicing of Bcl-x pre-inRNA in prostate and breast cancer cells. Analysis of apoptosis and cell death. J. Biol, Chem., 276, 16411-16417.
11. Lacerra,G., Sierakowska,H., Carestia,C., Fucharoen,S., Summerton,J., Weller,D. and Kole,R. (2000) Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. Proc. Natl Acad. Sci. USA, 97, 9591-9596.
12. Suwanmanee,T., Sierakowska,H., Lacerra,G., Svasti,S., Kirby,S., Walsh,C.E., Fucharoen,S. and Kole,R. (2002) Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides. Mol. Pharmacol., 62, 545-553.
13. Errington,S.J., Mann,C.J., Fletcher,S. and Wilton,S.D. (2003) Target selection for amisense oligonucleotide induced exon skipping in the dystrophin gene. J. Gene Med., 5, 518-527.
14. Pramono,Z.A., Takeshima,Y., Alimsardjono,H., Ishii,A., Takeda,S. and Matsuo,M. (1996) Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence. Biochem. Biophys. Res. Commun., 226, 445-449.
15. Gebski,B.L., Mann,C.J., Fletcher,S. and Wilton,S.D. (2003) Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum. Mol. Genet., 12, 1801-1811.
16. Sazani,P., Kang,S.H., Maier,M.A., Wei,C., Dillman,J., Summerton,J., Manoharan,M. and Kole,R. (2001) Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res., 29, 3965-3974.
17. Imanishi,T. and Obika,S. (2002) BNAs: novel nucleic acid analogs with a bridged sugar moiety. Chem. Commun., 1653-1659.
18. Petersen,M. and Wengel,J. (2003) LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol., 21, 74-81.
19. Renneherg,D. and Leumann,C.J. (2002) Watson-Crick base-pairing properties of tricyclo-DNA. J. Am. Chem, Soc., 124, 5993-6002.
20. Wahlestedt,C., Salmi,P., Good Kela,J., Johnsson,T., Hökfelt,T., Broberger,C., Porreca,F., Lai,J., Ren,K. et al. (2000) Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad. Sci. USA, 97, 5633-5638.
21. Arzumanov,A., Walsh,A.P., Rajwanshi,V.K., Kumar,R., Wengel,J. and Gait,M.J. (2001) Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides. Biochemistry, 40, 14645-14654.
22. Grunweller,A. Wyszko,E., Bieber,B., Jahnel,R., Erdmann,V.A. and Kurreck,J. (2003) Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res., 31, 3185-3193.
23. Kurreck,J., Wyszko,E., Gillen,C. and Erdmann,V.A. (2002) Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res., 30, 1911-1918.
24. Elayadi,A.N., Braasch,D.A. and Corey,D.R. (2002) Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase. Biochemistry, 41, 9973-9981.
25. Renneberg,D., Bouliong,E., Reber,U., Schümperli,D. and Leumann,C.J. (2002) Biological and antisense properties of tricyclo-DNA. Nucleic Acids Res., 30, 2751-2757.
26. Handschumacher,R.E., Harding,M.W., Rice,J., Drugge,R.J. and Speicher,D.W. (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science, 226, 544-547.
27. Sykes,K., Gething,M.J. and Sambrook,J. (1993) Proline isomerases function during heat shock. Proc. Natl Acad. Sci. USA, 90, 5853-5857.
28. Ansari,H., Greco,G. and Luban,J. (2002) Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export. Mol. Cell. Biol., 22, 6993-7003.
29. Brazin,K.N., Mallis,R.J., Fulton,D.B. and Andreotti,A.H. (2002) Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc. Natl Acad. Sci. USA, 99, 1899-1904.
30. Weisman,R., Creanor,J. and Fantes,P. (1996) A multicopy suppressor of a cell cycle defect in S. pombe encodes a heat shock-inducible 40 kDa cyclophilin-like protein. EMBO J., 15, 447-456.
31. Braaten,D., Franke,E.K. and Luban,J. (1996) Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol., 70, 3551-3560.
32. Franke,E.K., Yuan,H.E. and Luban,J. (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature, 372, 359-362.
33. Gamble,T.R., Vajdos,F.F., Yoo,S., Worthylake,D.K., Houseweart,M., Sundquist,W.I. and Hill,C.P. (1996) Crystal structure of human cyclophilin A bound to the amino-teminal domain of HIV-1 capsid. Cell, 87, 1285-1294.
34. Thali,M., Bukovsky,A., Kondo,E., Rosenwirth,B., Walsh,C.T., Sodroski,J. and Gottlinger,H.G. (1994) Functional association of cyclophilin A with HIV-1 virions. Nature, 372, 363-365.
35. Steinkasserer,A., Harrison,R., Billich,A., Hammerschmid,F., Werner,G., Wolff,B., Peichl,P., Palfi,G., Schnitzel,W., Mlynar,E. et al. (1995) Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. J. Virol., 69, 814-824.
36. Saphire,A.C., Bobardt,M.D. and Gallay,P.A. (2002) Cyclophilin a plays distinct rules in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation. J. Virol., 76, 4671-4677.
37. Saphire,A.C., Bobardt,M.D. and Gallay,P.A. (1999) Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J., 18, 6771-6785.
38. Luban,J. (1996) Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell, 87, 1157-1159.
39. Steffens,R. and Leumann,C.J. (1999) Synthesis and thermodynamic and biophysical properties of tricyclo-DNA. J. Am. Chem. Soc., 121, 3249-3255.
40. Dunckley,M.G., Manoharan,M., Villiet,P., Eperon,I.C. and Dickson,G. (1998) Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet., 7, 1083-1090.
41. Brun,C., Suter,D., Pauli,C., Dunant,P., Lochmüller,H., Burgunder,J.M., Schümperli,D. and Weis,J. (2003) U7 snRNAs induce correction of mutated dystrophin pre-mRNA by even skipping. Cell. Mol. Life Sci., 60, 557-566.